Clinical trials
Phase 3 trials in Puerto Rico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,462 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 17 |
| 2001 | 13 |
| 2002 | 22 |
| 2003 | 23 |
| 2004 | 30 |
| 2005 | 43 |
| 2006 | 56 |
| 2007 | 63 |
| 2008 | 64 |
| 2009 | 47 |
| 2010 | 56 |
| 2011 | 72 |
| 2012 | 62 |
| 2013 | 41 |
| 2014 | 58 |
| 2015 | 56 |
| 2016 | 43 |
| 2017 | 60 |
| 2018 | 52 |
| 2019 | 58 |
| 2020 | 59 |
| 2021 | 57 |
| 2022 | 58 |
| 2023 | 84 |
| 2024 | 77 |
| 2025 | 89 |
| 2026 | 44 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 925 |
| Active, not recruiting | 206 |
| Recruiting | 159 |
| Terminated | 146 |
| Unknown status | 11 |
| Enrolling by invitation | 7 |
| Not yet recruiting | 4 |
| Withdrawn | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 165 |
| AbbVie | 72 |
| Bristol-Myers Squibb | 69 |
| AstraZeneca | 64 |
| Novo Nordisk A/S | 62 |
| Novartis Pharmaceuticals | 57 |
| Gilead Sciences | 55 |
| Children's Oncology Group | 54 |
| Hoffmann-La Roche | 51 |
| National Cancer Institute (NCI) | 49 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 153 |
| HIV Infections | 90 |
| Diabetes Mellitus | 68 |
| Obesity | 49 |
| Breast Neoplasms | 48 |
| Acquired Immunodeficiency Syndrome | 43 |
| Hepatitis C | 42 |
| Overweight | 36 |
| Arthritis, Rheumatoid | 35 |
| Renal Insufficiency, Chronic | 34 |
Trials
Showing 1 to 25 of 1,462. Each trial links to its page on Pharma Observatory.
1,362 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.